Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases.


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
24 05 2023
Historique:
received: 14 01 2023
accepted: 04 05 2023
medline: 26 5 2023
pubmed: 25 5 2023
entrez: 24 5 2023
Statut: epublish

Résumé

Liver damage caused by toxicity can lead to various severe conditions, such as acute liver failure (ALF), fibrogenesis, and cirrhosis. Among these, liver cirrhosis (LC) is recognized as the leading cause of liver-related deaths globally. Unfortunately, patients with progressive cirrhosis are often on a waiting list, with limited donor organs, postoperative complications, immune system side effects, and high financial costs being some of the factors restricting transplantation. Although the liver has some capacity for self-renewal due to the presence of stem cells, it is usually insufficient to prevent the progression of LC and ALF. One potential therapeutic approach to improving liver function is the transplantation of gene-engineered stem cells. Several types of mesenchymal stem cells from various sources have been suggested for stem cell therapy for liver disease. Genetic engineering is an effective strategy that enhances the regenerative potential of stem cells by releasing growth factors and cytokines. In this review, we primarily focus on the genetic engineering of stem cells to improve their ability to treat damaged liver function. We also recommend further research into accurate treatment methods that involve safe gene modification and long-term follow-up of patients to increase the effectiveness and reliability of these therapeutic strategies.

Identifiants

pubmed: 37226279
doi: 10.1186/s13287-023-03364-x
pii: 10.1186/s13287-023-03364-x
pmc: PMC10210414
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

138

Informations de copyright

© 2023. The Author(s).

Références

Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Front Physiol. 2014 Jun 11;5:212
pubmed: 24966838
FEBS Lett. 2006 Nov 27;580(27):6289-94
pubmed: 17097645
Genome Biol. 2001;2(3):REVIEWS3005
pubmed: 11276432
Stem Cells. 2014 Nov;32(11):2818-23
pubmed: 25154380
Cancer Biol Ther. 2005 Feb;4(2):139-63
pubmed: 15725726
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4477-82
pubmed: 15070743
Mol Med. 2000 Feb;6(2):96-103
pubmed: 10859026
Stem Cells. 2006 Sep;24(9):2130-9
pubmed: 16741227
Biochemistry. 2009 Mar 3;48(8):1838-46
pubmed: 19199380
J Pathol. 1989 Jul;158(3):253-60
pubmed: 2769486
Nature. 2008 Dec 18;456(7224):980-4
pubmed: 19043405
FEBS J. 2013 Jan;280(2):505-24
pubmed: 22413991
J Hepatol. 2018 May;68(5):1033-1048
pubmed: 29175243
J Hepatol. 2019 Apr;70(4):722-734
pubmed: 30582979
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):936-41
pubmed: 21900788
J Biol Chem. 2001 May 18;276(20):17058-62
pubmed: 11279127
Am J Physiol. 1996 Jul;271(1 Pt 1):G121-9
pubmed: 8760115
Stem Cell Res Ther. 2020 Nov 27;11(1):512
pubmed: 33246509
Oncogene. 2001 Jun 7;20(26):3332-40
pubmed: 11423983
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12301-6
pubmed: 18719101
Biochem J. 1995 Aug 15;310 ( Pt 1):73-81
pubmed: 7544118
Acta Pharm Sin B. 2016 Sep;6(5):393-408
pubmed: 27709008
Curr Med Chem. 2012;19(28):4850-60
pubmed: 22709007
Can J Gastroenterol Hepatol. 2018 Jan 29;2018:4197857
pubmed: 29670867
Am J Physiol Gastrointest Liver Physiol. 2015 Jan 15;308(2):G85-91
pubmed: 25377314
Nature. 2020 Jan;577(7791):566-571
pubmed: 31915377
Hepatology. 2010 Jan;51(1):297-305
pubmed: 19998274
Front Immunol. 2015 Aug 21;6:429
pubmed: 26347749
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:188-202
pubmed: 21199531
Hepatobiliary Pancreat Dis Int. 2013 Feb;12(1):60-7
pubmed: 23392800
J Cell Mol Med. 2017 Nov;21(11):2963-2973
pubmed: 28544786
Gene Ther. 2000 Jul;7(14):1244-9
pubmed: 10918494
Endocrinol Metab Clin North Am. 2012 Jun;41(2):425-43, vii-viii
pubmed: 22682639
J Biochem. 1996 Apr;119(4):591-600
pubmed: 8743556
Stem Cells Dev. 2015 Mar 15;24(6):791-801
pubmed: 25315017
Stem Cell Res Ther. 2020 Sep 14;11(1):395
pubmed: 32928296
Science. 1991 Feb 15;251(4995):802-4
pubmed: 1846706
Curr Opin Biotechnol. 2009 Oct;20(5):568-74
pubmed: 19837579
Cell Biosci. 2020 Oct 27;10:123
pubmed: 33117520
J Biol Chem. 2008 Mar 21;283(12):7844-52
pubmed: 18223258
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18117-22
pubmed: 15608062
J Biol Chem. 1998 Jul 3;273(27):17286-95
pubmed: 9642300
Cytokine. 2008 Jul;43(1):54-62
pubmed: 18511291
Stem Cell Res Ther. 2017 Jul 5;8(1):162
pubmed: 28679425
Hepatology. 2014 Oct;60(4):1346-55
pubmed: 24913549
Liver Int. 2011 Aug;31(7):911-9
pubmed: 21733081
Lab Invest. 2005 Mar;85(3):376-87
pubmed: 15640832
Nat Rev Mol Cell Biol. 2012 Oct;13(10):616-30
pubmed: 22992590
Stem Cell Res Ther. 2016 Nov 22;7(1):172
pubmed: 27876093
Dig Dis Sci. 2012 Apr;57(4):925-34
pubmed: 22271415
Gastroenterology. 2003 Jul;125(1):178-91
pubmed: 12851882
J Tongji Med Univ. 1999;19(1):53-5
pubmed: 12840877
J Gastroenterol. 2012 May;47(5):491-7
pubmed: 22488349
Nature. 1989 Nov 23;342(6248):440-3
pubmed: 2531289
Cell. 2012 Mar 16;148(6):1172-87
pubmed: 22424228
BMC Med. 2014 Sep 18;12:159
pubmed: 25286285
World J Gastroenterol. 2014 Oct 28;20(40):14884-94
pubmed: 25356048
EMBO J. 1998 Jun 1;17(11):3091-100
pubmed: 9606191
J Biol Chem. 2001 Oct 19;276(42):38502-10
pubmed: 11502752
J Hepatol. 2013 Jul;59(1):183-5
pubmed: 23353868
Genes Dev. 1998 Oct 1;12(19):3084-95
pubmed: 9765209
Exp Ther Med. 2017 Sep;14(3):2568-2576
pubmed: 28962196
Stem Cells Int. 2019 Dec 01;2019:2782548
pubmed: 31871465
Hepatology. 2003 Jun;37(6):1249-53
pubmed: 12774000
Digestion. 2011;83(1-2):32-40
pubmed: 20847561
Am J Hematol. 2007 Nov;82(11):949-54
pubmed: 17724706
PLoS One. 2011;6(9):e25442
pubmed: 21980458
EMBO Rep. 2010 Feb;11(2):97-105
pubmed: 20075988
Stem Cell Res Ther. 2019 May 27;10(1):149
pubmed: 31133062
Cell Immunol. 2018 Apr;326:24-32
pubmed: 28778535
Trends Cell Biol. 1998 Oct;8(10):404-10
pubmed: 9789329
Gastroenterology. 2004 Oct;127(4):1189-97
pubmed: 15480996
EBioMedicine. 2018 Oct;36:140-150
pubmed: 30197023
N Engl J Med. 2016 Aug 25;375(8):767-77
pubmed: 27557303
Cell Mol Life Sci. 2020 Jul;77(14):2771-2794
pubmed: 31965214
Nat Genet. 2003 Jul;34(3):292-6
pubmed: 12808453
Free Radic Biol Med. 2009 Aug 15;47(4):424-30
pubmed: 19463946
Tissue Eng Part B Rev. 2014 Jun;20(3):206-10
pubmed: 24450831
Cell Death Dis. 2018 Jun 18;9(7):716
pubmed: 29915308
J Biol Chem. 2000 Jan 14;275(2):1226-32
pubmed: 10625667
Eur Surg Res. 2015;54(3-4):162-77
pubmed: 25633583
Oncogene. 2012 Feb 16;31(7):818-27
pubmed: 21765462
Cell Physiol Biochem. 2016;40(5):1117-1128
pubmed: 27960154
Mol Cell Biol. 1994 Jun;14(6):3752-62
pubmed: 8196618
Cancer Sci. 2010 Oct;101(10):2254-61
pubmed: 20860603
FEBS Lett. 2022 Dec;596(24):3176-3190
pubmed: 35849431
Science. 2004 Jul 30;305(5684):626-9
pubmed: 15286356
J Histochem Cytochem. 2006 Dec;54(12):1401-12
pubmed: 16957164
Stem Cells Transl Med. 2017 Jan;6(1):51-59
pubmed: 28170176
Biomedicines. 2014 Oct 31;2(4):275-300
pubmed: 28548072
Int J Hepatol. 2016;2016:5452487
pubmed: 27057357
Nat Med. 2005 Nov;11(11):1188-96
pubmed: 16227992
J Hepatol. 2014 Feb;60(2):442-52
pubmed: 24045150
Int J Med Sci. 2014 Apr 24;11(6):626-33
pubmed: 24782653
Leukemia. 2001 Apr;15(4):515-22
pubmed: 11368354
Inflamm Regen. 2019 Jun 6;39:12
pubmed: 31182982
PLoS One. 2012;7(7):e41392
pubmed: 22844472
J Cell Mol Med. 2017 Oct;21(10):2491-2502
pubmed: 28382720
Rheumatology (Oxford). 2004 Jun;43 Suppl 3:iii2-iii9
pubmed: 15150426
J Biol Chem. 2011 Oct 28;286(43):37222-36
pubmed: 21878648
Front Cell Dev Biol. 2020 Feb 18;8:79
pubmed: 32133359
Ann Hepatol. 2016 Mar-Apr;15(2):260-70
pubmed: 26845604
N Engl J Med. 2000 Sep 7;343(10):732-4
pubmed: 10974140
Liver Int. 2011 Aug;31(7):932-9
pubmed: 21092070
Ann Gastroenterol. 2017;30(3):357-363
pubmed: 28469367
Front Cell Dev Biol. 2020 Feb 07;8:55
pubmed: 32117981
J Neurosci. 1996 Jan 15;16(2):486-96
pubmed: 8551333
Kidney Int. 2002 Oct;62(4):1149-59
pubmed: 12234285
Cancer Lett. 1996 Dec 20;110(1-2):49-55
pubmed: 9018080
Int J Clin Exp Med. 2015 Aug 15;8(8):12774-82
pubmed: 26550191
Front Endocrinol (Lausanne). 2018 Aug 30;9:503
pubmed: 30214428

Auteurs

Farnaz Sani (F)

Hematology and Cell Therapy Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Mahsa Sani (M)

Department of Tissue Engineering and Cell Therapy, School of Advanced Technologies in Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Zahra Moayedfard (Z)

Department of Tissue Engineering and Cell Therapy, School of Advanced Technologies in Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Darayee (M)

Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.

Lobat Tayebi (L)

Marquette University School of Dentistry, Milwaukee, WI, 53233, USA.

Negar Azarpira (N)

Transplant Research Center, Shiraz University of Medical Sciences, Khalili Street, P.O. Box: 7193711351, Shiraz, Iran. negarazarpira@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH